Feature |
Featured
-
-
Feature |
Dendritic cells in cancer immunotherapy
Camille M. Le Gall, Jorieke Weiden, Loek J. Eggermont and Carl G. Figdor provide an overview of immunotherapeutics for cancer treatment that harness dendritic cells, their challenges in clinical use, and approaches employed to enhance their recruitment and activation to promote effective anti-tumour immunity.
- Camille M. Le Gall
- , Jorieke Weiden
- & Carl G. Figdor
-
Editorial |
Cells and materials in immunotherapy
As the interaction of the immune system with the tumour microenvironment becomes increasingly understood, more evidence indicates how immunotherapy can be employed to better eliminate cancers.
